https://www.selleckchem.com/sc....reening/natural-prod
https://www.selleckchem.com/sc....reening/natural-prod
Developments, challenges and viewpoints regarding massive compound approaches inside molecular spectroscopy from the condensed stage. 68). IRM at 30 days was 5%, without differences by donor type (P = .106). Overall, 208 patients experienced ≥1 VIs (first occurrence among CMV, HHV6, ADV, BKPyV-HC) at a median time of 20 days after HSCT CIF at 90 days was 91%, significantly higher in MUD and haplo (P = .0089). By multivariate analysis, also acute GV